←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, HER2 Targeted Therapy
John (Andrew) Strickler
MD
🏢Duke Cancer Institute🌐USA
Associate Professor of Medicine, Gastrointestinal Oncology
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrew Strickler led the MOUNTAINEER trial evaluating tucatinib plus trastuzumab in HER2 positive metastatic colorectal cancer. His clinical investigation supports biomarker-driven care for rare molecular subsets and novel antibody drug conjugates in gastrointestinal malignancies.
Share:
🧪Research Fields 研究领域
HER2 CRC
tucatinib
trastuzumab deruxtecan
MOUNTAINEER
CRC drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 John (Andrew) Strickler 的研究动态
Follow John (Andrew) Strickler's research updates
留下邮箱，当我们发布与 John (Andrew) Strickler（Duke Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment